DIAGENODE

Work Package(s) to which it is related : WP3, transversal to all research WP.

Objectives and scientific expected results:
i) to develop epigenomics to identify variable regions that could account for MLL-rearranged-AML specificity,
ii) evaluate the impact of epigenomic variations on disease characteristics by confronting epigenomics and clinical data